$1.32Day Range$1.44
Key Statistics
Market Cap
$71.37M
Shares Outstanding
52.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 17, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$1.32
Day High
$1.44
Day Low
$1.32
Volume
22.1K
VWAP
$1.36
Prev Close
$1.32
Transactions
--
Acc. Volume
--
About OKYO Pharma Limited Ordinary Shares
OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.
Identifiers
- CIK
- 0001849296
- Ticker Root
- OKYO
About OKYO Pharma Limited Ordinary Shares (OKYO) Stock
OKYO Pharma Limited Ordinary Shares (OKYO) closed the 2026-09-18 session at $1.36, up 3.03% versus the previous close (+0.04). The stock opened at $1.32 and traded between $1.32 and $1.44 during that session. Session trading volume was 22K shares. The volume-weighted average price (VWAP) is $1.36.
OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.
OKYO Pharma Limited Ordinary Shares has a market capitalization of $71.4 million. OKYO is listed on the XNAS exchange. The company employs approximately 5 people. The recorded listing date is 2022-05-17.
On this page you can find market OKYO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.